The AI software company has unveiled the full range of modules for the Brainomix 360 system designed for stroke care. Brainomix 360, a comprehensive program developed to support clinicians in their imaging-based treatment decisions throughout the entire spectrum of stroke care, from initial scans to more advanced imaging processes, has been introduced to the market.
Powered by cutting-edge AI technology, Brainomix 360 provides real-time analysis of brain imaging to aid in treatment and mobility decisions for stroke patients. Recent clearances from the U.S. Food and Drug Administration encompass the software modules Brainomix 360 e-CTP and MRI. These modules play a crucial role in guiding treatment decisions for patients arriving at the hospital six to twelve hours post-stroke onset.
Furthermore, Brainomix has introduced two new alert systems, Brainomix 360 Triage LVO and ICH, which promptly notify clinicians when a bleed or large vessel occlusion (LVO) is suspected. The identification of LVO can significantly impact a patient’s suitability for structural thrombectomy, as stated by Brainomix.
Brainomix has also announced its expansion into the United States market, aiming to establish a strong presence and broaden the distribution of its products across various medical systems.
